Skip to main content
SpringerLink
Log in

A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background: Insofar as the inherited prothrombotic single nucleotide polymorphisms (SNPs) factor V G1691A (FV-Leiden), prothrombin (PRT) G20210A, and methylenetetrahydrofolate reductase (MTHFR), C677T are inherited risk factors of venous thromboembolism (VTE), the aim of this study was to determine the prevalence of single and combined SNPs in 198 patients with documented deep venous thrombosis (DVT), and 697 control subjects, and to estimate the associated risks.

Methods: Factor V-Leiden, PRT G20210A, and MTHFR C677T were analyzed by PCR and restriction fragment length polymorphism (RFLP).

Results: The prevalence of the heterozygote and homozygous variants for FV-Leiden (52.02 vs. 14.78%, RR 6.28), PRT G20210A (19.2 vs. 3.6%; RR 6.38), and to a lesser extent the T/T genotype of MTHFR C677T (20.71 vs. 11.0%; RR 1.49) were higher among DVT patients vs. controls, respectively. Two or more SNPs were detected in 90 of 198 patients (45.5%) and in 60 of 697 controls (8.6%), with odds ratios of 16.754 for joint occurrence of FV-Leiden and PRT G20210A, 10.471 for FV-Leiden and MTHFR C677T, and 6.283 for PRT G20210A SNPs and MTHFR 677T/T. Logistic regression analysis showed a further increased odds for FV-Leiden in combination with PRT G20210A (85.198) or homozygous MTHFR C677T (81.133), and to a lesser extent for PRT G20210A in combination with homozygous MTHFR C677T (20.812).

Conclusions: This indicates that FV-Leiden and PRT G20210A, more than MTHFR C677T, are important risk factors for DVT, and that the presence of more than one prothrombotic SNPs was associated with a significant risk of DVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rosendaal F.R. Venous thrombosis: A multicausal disease. Lancet 1999;353:1167–1173.

    Article  PubMed  Google Scholar 

  2. Bertina RM, Koeleman BPC, Koster T, et~al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–67.

    Article  PubMed  Google Scholar 

  3. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504–1508.

    PubMed  Google Scholar 

  4. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–3703.

    PubMed  Google Scholar 

  5. Tamim H, Finan RR, Almawi WY. Prevalence of two thrombophilia predisposing mutations: Factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost 2002;88:691–692.

    PubMed  Google Scholar 

  6. Zivelin A, Griffin JH, Xu X, et~al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397–402.

    PubMed  Google Scholar 

  7. Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N, Factor V. prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease. J Thrombosis Thrombolysis 2004;17:199–205.

    Article  Google Scholar 

  8. Couturaud F, Oger E, Abalain JH, et~al. Methylenetetrahydrofolate reductase C677T genotype and venous thrombo-embolic disease. Respiration 2000;67:657–661.

    Article  PubMed  Google Scholar 

  9. Shmeleva VM, Kapustin SI, Papayan LP, Sobczynska-Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb Res 2003;111:351–356.

    Article  PubMed  Google Scholar 

  10. Ray JG, Shmorgun D, Chan, WS. Common C677T polymorphism of the methylene-tetrahydrofolate reductase gene and the risk of venous thromboembolism: Meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32:51–58.

    Article  PubMed  Google Scholar 

  11. Zalavras ChG, Giotopoulou S, Dokou E, et~al. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol 2002;21:268–271.

    PubMed  Google Scholar 

  12. De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost 2000;26:305–311.

    Article  PubMed  Google Scholar 

  13. Morelli VM, Lourenco DM, D’Almeida V, et~al. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 2002;13:271–275.

    Article  PubMed  Google Scholar 

  14. Keijzer MB, den Heijer M, Blom HJ, et~al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate-reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88:723–728.

    PubMed  Google Scholar 

  15. Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis. Haemostasis 2001;31:99–105.

    Article  PubMed  Google Scholar 

  16. Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, et~al. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Int Angiol 2003;22:79–82.

    PubMed  Google Scholar 

  17. Aznar J, Vaya A, Estelles A, et~al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 2000;85:1271–1276.

    PubMed  Google Scholar 

  18. Emmerich J, Rosendaal FR, Cattaneo M, et~al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism–pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost 2001;86:809–816.

    PubMed  Google Scholar 

  19. Salomon O, Steinberg DM, Zivelin A, et~al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511–518.

    PubMed  Google Scholar 

  20. Cattaneo M, Tsai MY, Bucciarelli P, et~al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997;17:1662–1666.

    PubMed  Google Scholar 

  21. Fujimura H, Kawasaki T, Sakata T, et~al. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia. Thromb Res 2000;98:1–8.

    Article  PubMed  Google Scholar 

  22. Rintelen C, Mannhalter C, Lechner K, et~al. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylene-tetrahydrofolate-reductase gene. Blood Coagul Fibrinolysis 1999;10:101–105.

    PubMed  Google Scholar 

  23. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 2000;65:45–49.

    Article  PubMed  Google Scholar 

  24. Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 2001;86:723–724.

    PubMed  Google Scholar 

  25. De Stefano V, Rossi E, Paciaroni K, et~al. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Haematologica 2003;88:61–66.

    PubMed  Google Scholar 

  26. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222–1231.

    Article  PubMed  Google Scholar 

  27. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993;72:477–481.

    Article  PubMed  Google Scholar 

  28. Simioni P, Prandoni P, Lensing AW, et~al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000;96:3329–3333.

    PubMed  Google Scholar 

  29. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of anticoagulation. Thromb Haemost 1999;81:684–689.

    PubMed  Google Scholar 

  30. Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol 2002;71:285–290.

    Article  PubMed  Google Scholar 

  31. Margaglione M, Brancaccio V, Giuliani N, et~al. Increased risk for venous thrombosis in carriers of the prothrombin G → A20210 gene variant. Ann Intern Med 1998; 129:89–93.

    PubMed  Google Scholar 

  32. Vargas M, Soto I, Pinto CR, et~al. The prothrombin 20210A allele and factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis 1999;10:39–41.

    PubMed  Google Scholar 

  33. Isotalo PA, Donnelly JG. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000;5:59–66.

    PubMed  Google Scholar 

  34. Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998;79:254–258.

    PubMed  Google Scholar 

  35. Margaglione M, D’Andrea G, D’Addedda M, et~al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost. 1998;79:907–911.

    PubMed  Google Scholar 

  36. Makris M, Preston FE, Beauchamp NJ, et~al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997;78:1426–1429.

    PubMed  Google Scholar 

  37. Howard TE, Marusa M, Boisza J, et~al. The prothrombin gene 3′-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency. Blood 1998;91:1092.

    PubMed  Google Scholar 

  38. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133–1134.

    Article  PubMed  Google Scholar 

  39. Zama T, Murata M, Ono F, et~al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int J Haematol 1996;65:71–78.

    Article  Google Scholar 

  40. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997;78:1430–1433.

    PubMed  Google Scholar 

  41. Rosendaal FR, Doggen CJM, Zivelin A, et~al. Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 1998;79:706–708.

    PubMed  Google Scholar 

  42. Zoller B, Norlund L, Leksell H, et~al. High prevalence of the FV R506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. Thromb Res 1996;83:475–477.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Al-Jawhara Center for Molecular Medicine, Genetics, and Inherited Diseases, Arabian Gulf University, Manama, Bahrain

    Wassim Y. Almawi & Georgina Timson

  2. Faculty of Health Sciences, American University of Beirut, Beirut

    Hala Tamim

  3. St. Georges University Hospital, Beirut

    Raghid Kreidy, Elias Rahal, Ramzi R. Finan & Noha Irani-Hakime

  4. Islamic Hospital, Tripoli, Lebanon

    Malak Nabulsi

  5. Al-Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, Arabian Gulf University, P.O. Box 22979, Manama, Bahrain

    Wassim Y. Almawi

Authors
  1. Wassim Y. Almawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hala Tamim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raghid Kreidy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgina Timson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elias Rahal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Malak Nabulsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ramzi R. Finan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Noha Irani-Hakime
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wassim Y. Almawi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Almawi, W.Y., Tamim, H., Kreidy, R. et al. A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis. J Thromb Thrombolysis 19, 189–196 (2005). https://doi.org/10.1007/s11239-005-1313-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-005-1313-x

Key Words

Search

Navigation